drugset / Trial / NCT04984954
Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Objective to evaluate the effect of Shexiang Baoxin Pill on myocardial ischemia in patients with coronary microvascular dysfunction (non obstructive coronary heart disease) through a randomized, double-blind, placebo-controlled clinical multicenter study.At the same time, the effects of exercise tolerance and quality of life were also observed.
Timeline
- Start
- 2021-01-28
- Primary completion
- 2023-12-31
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MUSK pill | Unknown | 4 unknown | — |